Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
Caffeine shows promise for hair loss, but evidence remains preliminary A systematic review identified nine studies—five randomized controlled trials, three prospective cohorts and one twin‑twin cohort—evaluating caffeine interventions for hair…
Breakthroughs in atopic dermatitis are redefining treatment from the inside out. Discover how new data on race, microbes, and patient preferences are transforming the way we think about AD. In…
Barrier boost with benefits - new topical cream raises filaggrin, hyaluronic acid and lipids while improving tolerability A novel topical cream moisturizer produced meaningful biological and clinical improvements in both…
Exosome complex after microneedling shows promising hair‑regrowth signals in a 30‑patient series In a 30‑subject study (15 men, 15 women; mean age 50.2 years) treated with an Exosome Regenerative Complex+…
Think beyond inflammation: SAIGE framing reframes pediatric AD prevention and care A seven‑expert global panel of pediatric dermatologists and dermatologists used a modified Delphi process to produce five consensus statements…
Dupilumab delivers — but many patients need more than monotherapy over time In a US retrospective cohort (OM1 PremiOM™ AD) of 5,200 patients who started dupilumab between 2017-2021 (208 children, 430…